Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Neves, F. S. Pires, A. P. Vaz, C. Souto Moura, P. Bastos, H. Queiroga, V. Hespanhol, G. Fernandes (Porto, Portugal). Subtyping agreement between small cyto-histological samples and surgical specimens in NSCLC patients. Eur Respir J 2013; 42: Suppl. 57, 2924

Member's Comments

No comment yet.

Related content which might interest you: Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Feasibility of OSNA in EBUS-TBNA of lung cancer patients Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall Year: 2014 Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis? Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 The prognostic value of D-dimer in lung carcinoma Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 EBUS/EUS – Cell smears or cytoblocks? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Added value of EUS-B to EBUS for lung cancer staging Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results? Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Segmentectomy for second lung cancer after lobectomy Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015